← Evidence map

ReviewAnticancer research

HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer.

Kazi M Ahmed et al.PubMed ↗Full text ↗

No numbers read from the abstract.

33 papers cite it

2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
cites it
Full record →Abstract, authors, funding and every citing paper · PMID 17201139